Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Net Margin (2020 - 2022)

Historic Net Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 2134.2%.

  • Therapeutics' Net Margin fell 2803400.0% to 2134.2% in Q2 2022 from the same period last year, while for Mar 2023 it was 10900.68%, marking a year-over-year decrease of 86275600.0%. This contributed to the annual value of 5618.53% for FY2022, which is 38035800.0% down from last year.
  • As of Q2 2022, Therapeutics' Net Margin stood at 2134.2%, which was down 2803400.0% from 3241.34% recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Net Margin registered a high of 957.53% during Q3 2020, and its lowest value of 3241.34% during Q1 2022.
  • For the 3-year period, Therapeutics' Net Margin averaged around 1719.4%, with its median value being 1629.55% (2021).
  • In the last 5 years, Therapeutics' Net Margin soared by 538500bps in 2021 and then plummeted by -18899500bps in 2022.
  • Over the past 3 years, Therapeutics' Net Margin (Quarter) stood at 978.11% in 2020, then tumbled by -142bps to 2371.56% in 2021, then grew by 10bps to 2134.2% in 2022.
  • Its Net Margin stands at 2134.2% for Q2 2022, versus 3241.34% for Q1 2022 and 2371.56% for Q4 2021.